Mats Heyman
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia (NCT04307576) | Mats Heyman | 2020-07-13 |
| A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia (NCT03911128) | Mats Heyman | 2019-08-29 |
Track Mats Heyman automatically
Every clearance here is in the API, with alerts when new ones post.